Markers of bone metabolism in congestive heart failure

Clinica Chimica Acta

Volumn 366, Issue 1-2, 2006, Pages 27-36

  Zittermann, Armin ^a   Schleithoff, Stefanie S ^a   Koerfer, Reiner ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Bone formation; Bone resorption; Congestive heart failure; Heart transplantation

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALENDRONIC ACID; ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; ANTIVITAMIN K; BIOLOGICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CALCINEURIN INHIBITOR; CALCITONIN; CALCITRIOL; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; CORTICOSTEROID; ETIDRONIC ACID; LOOP DIURETIC AGENT; OSTEOCALCIN; PAMIDRONIC ACID; SALCATONIN; SIALOPROTEIN; VITAMIN D; VITAMIN D DERIVATIVE;

BLOOD ANALYSIS; BONE DENSITY; BONE METABOLISM; CARDIAC GRAFT REJECTION; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; FRACTURE; GRAFT RECIPIENT; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; LABORATORY TEST; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RICKETS; RISK ASSESSMENT; VITAMIN SUPPLEMENTATION;

BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE RESORPTION; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; OSTEOPOROSIS;

EID: 33644674991     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2005.10.006     Document Type: Review

References (78)

1. M. Jessup, and S. Brozena Heart failure N Engl J Med 348 2003 2007 2018
2. W.J. Remme, and K. Swedberg Guidelines for the diagnosis and treatment of chronic heart failure Eur Heart J 22 2001 1527 1560
3. F.D. Hobbs The scale of heart failure: diagnosis and management issues for primary care Heart 82 Suppl. 4 1999 IV8 IV10
4. M.R. Cowie, A. Mosterd, and D.A. Wood The epidemiology of heart failure Eur Heart J 18 1997 208 225
5. B. Pieske, and G. Hasenfuss Pathophysiological basis of heart failure Ther Umsch 57 2000 284 292
6. G.S. Bleumink, A.M. Knetsch, and M.C. Sturkenboom Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study Eur Heart J 25 2004 1614 1619
7. D. Levy, S. Kenchaiah, and M.G. Larson Long-term trends in the incidence of and survival with heart failure N Engl J Med 347 2002 1397 1402
8. A. Zittermann Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 89 2003 552 572
9. National Osteoporosis Foundation. Disease statistics. www.nof.org/osteoporosis/stats.htm. Accessed June 17, 2005.
10. J. Pfeilschifter Bone metabolism and the parameters of its activity Internist (Berl) 31 1990 727 736
11. H. Schiessl, H.M. Frost, and W.S. Jee Estrogen and bone-muscle strength and mass relationships Bone 22 1998 1 6
12. J.E. Aubin, and E. Bonnelye Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption Osteoporos Int 11 2000 905 913
13. A. Zittermann, J. Ruhl, and H.K. Berthold Oral contraceptives moderately effect bone resorption markers and serum-soluble interleukin-6 receptor concentrations Calcif Tissue Int 70 2002 11 21
14. S.A. Huber, P. Sakkinen, D. Conze, N. Hardin, and R. Tracy Interleukin-6 exacerbates early atherosclerosis in mice Arterioscler Thromb Vasc Biol 19 1999 2364 2367
15. K. Scheld, A. Zittermann, and M. Heer Nitrogen metabolism and bone metabolism markers in healthy adults during 16 weeks of bed rest Clin Chem 47 2001 1688 1695
16. A. Zittermann, M. Heer, and A. Caillot-Augusso Microgravity inhibits intestinal calcium absorption as shown by a stable strontium test Eur J Clin Invest 30 2000 1036 1043
17. A. Zittermann, I. Schwarz, and K. Scheld Physiologic fluctuations of serum estradiol levels influence biochemical markers of bone resorption in young women J Clin Endocrinol Metab 85 2000 95 101
18. H.W. Woitge, A. Knothe, and K. Witte Circannual rhythms and interactions of vitamin D metabolites, parathyroid hormone, and biochemical markers of skeletal homeostasis: a prospective study J Bone Miner Res 15 2000 2443 2450
19. 3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study Clin Rheumatol 24 2005 232 238
20. P.D. Delmas The use of bisphosphonates in the treatment of osteoporosis Curr Opin Rheumatol 17 2005 462 466
21. 3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial Ann Intern Med 125 1996 961 968
22. C.Y. Guo, A. Johnson, T.J. Locke, and R. Eastell Mechanisms of bone loss after cardiac transplantation Bone 22 1998 267 271
23. Y. Sato, Y. Honda, H. Kunoh, and K. Oizumi Long-term oral anticoagulation reduces bone mass in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation Stroke 28 1997 2390 2394
24. H.W. Woitge, and M.J. Seibel Risk assessment for osteoporosis: II. Biochemical markers of bone turnover: bone resorption indices Clin Lab Med 20 2000 503 525 [vi]
25. A.C. Looker, D.C. Bauer, and C.H. Chesnut III Clinical use of biochemical markers of bone remodeling: current status and future directions Osteoporos Int 11 2000 467 480
26. L. Brunvand, P. Haga, S.E. Tangsrud, and E. Haug Congestive heart failure caused by vitamin D deficiency? Acta Paediatr 84 1995 106 108
27. A. Gillor, P. Groneck, J. Kaiser, and A. Schmitz-Stolbrink Congestive heart failure in rickets caused by vitamin D deficiency Monatsschr Kinderheilkd 137 1989 108 110
28. H. Olgun, N. Ceviz, and B. Ozkan A case of dilated cardiomyopathy due to nutritional vitamin D deficiency rickets Turk J Pediatr 45 2003 152 154
29. S. Uysal, A.G. Kalayci, and K. Baysal Cardiac functions in children with vitamin D deficiency rickets Pediatr Cardiol 20 1999 283 286
30. L. Rejnmark, P. Vestergaard, L. Heickendorff, F. Andreasen, and L. Mosekilde Effects of thiazide- and loop-diuretics, alone or in combination, on calcitropic hormones and biochemical bone markers: a randomized controlled study J Intern Med 250 2001 144 153
31. A. Zittermann Effects of vitamin K on calcium and bone metabolism Curr Opin Clin Nutr Metab Care 4 2001 483 487
32. K.J. Obrant, S.M. Kakonen, and J. Astermark The proportion of carboxylated to total or intact osteocalcin in serum discriminates warfarin-treated patients from control subjects J Bone Miner Res 14 1999 555 560
33. M.H. Knapen, B.S. Hellemons-Boode, and M. Langenberg-Ledeboer Effect of oral anticoagulant treatment on markers for calcium and bone metabolism Haemostasis 30 2000 290 297
34. P. Szulc, M.C. Chapuy, P.J. Meunier, and P.D. Delmas Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women J Clin Invest 91 1993 1769 1774
35. M.E. Ooms, P. Lips, A. Van Lingen, and H.A. Valkenburg Determinants of bone mineral density and risk factors for osteoporosis in healthy elderly women J Bone Miner Res 8 1993 669 675
36. H.N. Blansfield, and C.B. Andrew Osteoporosis: a factor in mortality following cardiac surgery Conn Med 64 2000 71 73
37. M.E. Ooms, J.C. Roos, P.D. Bezemer, W.J. van der Vijgh, L.M. Bouter, and P. Lips Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial J Clin Endocrinol Metab 80 1995 1052 1058
38. E. Shane, D. Mancini, and K. Aaronson Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure Am J Med 103 1997 197 207
39. S.S. Schleithoff, A. Zittermann, and B. Stuttgen Low serum levels of intact osteocalcin in patients with congestive heart failure J Bone Miner Metab 21 2003 247 252
40. D.M. Kriegsman, D.J. Deeg, J.T. van Eijk, B.W. Penninx, and A.J. Boeke Do disease specific characteristics add to the explanation of mobility limitations in patients with different chronic diseases? A study in the Netherlands J Epidemiol Community Health 51 1997 676 685
41. M.C. Albanese, M. Plewka, and D. Gregori Use of medical resources and quality of life of patients with chronic heart failure: a prospective survey in a large Italian community hospital Eur J Heart Fail 1 1999 411 417
42. P.G. Avery, I.R. Arnold, P.J. Hubner, and S.J. Iqbal Cardiac failure secondary to hypocalcaemia of nutritional osteomalacia Eur Heart J 13 1992 426 427
43. E. Christ, A. Linka, and G. Junga Bone density and laboratory parameters of bone metabolism in patients with terminal heart disease Schweiz Med Wochenschr 126 1996 1553 1559
44. K. Nishio, S. Mukae, and S. Aoki Congestive heart failure is associated with the rate of bone loss J Intern Med 253 2003 439 446
45. N. Cohen, O. Gorelik, and D. Almoznino-Sarafian Renal dysfunction in congestive heart failure, pathophysiological and prognostic significance Clin Nephrol 61 2004 177 184
46. D.S. Silverberg, D. Wexler, and M. Blum The interaction between heart failure, renal failure and anemia-the cardio-renal anemia syndrome Blood Purif 22 2004 277 2784
47. J. VanCleemput, W. Daenen, J. Nijs, P. Geusens, J. Dequeker, and J. Vanhaecke Timing and quantification of bone loss in cardiac transplant recipients Transpl Int 8 1995 196 200
48. M.A. Rodino, and E. Shane Osteoporosis after organ transplantation Am J Med 104 1998 459 469
49. A.H. Lee, R.L. Mull, and G.F. Keenan Osteoporosis and bone morbidity in cardiac transplant recipients Am J Med 96 1994 35 41
50. D. Thiebaud, M.A. Krieg, D. Gillard-Berguer, A.F. Jacquet, J.J. Goy, and P. Burckhardt Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation Eur J Clin Invest 26 1996 549 555
51. J.S. Muchmore, D.K. Cooper, Y. Ye, V. Schlegel, A. Pribil, and N. Zuhdi Prevention of loss of vertebral bone density in heart transplant patients J Heart Lung Transplant 11 1992 959 963 [discussion 63-4]
52. S.D. Anker, A.L. Clark, M.M. Teixeira, P.G. Hellewell, and A.J. Coats Loss of bone mineral in patients with cachexia due to chronic heart failure Am J Cardiol 83 1999 612 615 [A10]
53. D.O. Taylor, L.B. Edwards, M.M. Boucek, E.P. Trulock, B.M. Keck, and M.I. Hertz The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report-2004 J Heart Lung Transplant 23 2004 796 803
54. E. Shane, M. Rivas, and R.B. Staron Fracture after cardiac transplantation: a prospective longitudinal study J Clin Endocrinol Metab 81 1996 1740 1746
55. R. Ramsey-Goldman, J.E. Dunn, and D.D. Dunlop Increased risk of fracture in patients receiving solid organ transplants J Bone Miner Res 14 1999 456 463
56. A. Fahrleitner, G. Prenner, and G. Leb Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation Bone 32 2003 96 106
57. P.N. Sambrook, P.J. Kelly, and A.M. Keogh Bone loss after heart transplantation: a prospective study J Heart Lung Transplant 13 1994 116 120 [discussion 21]
58. K. Boncimino, D.J. McMahon, V. Addesso, J.P. Bilezikian, and E. Shane Magnesium deficiency and bone loss after cardiac transplantation J Bone Miner Res 14 1999 295 303
59. E. Shane, M.A. Rodino, and D.J. McMahon Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study J Heart Lung Transplant 17 1998 1089 1096
60. G.M. Rich, G.H. Mudge, G.L. Laffel, and M.S. LeBoff Cyclosporine A and prednisone-associated osteoporosis in heart transplant recipients J Heart Lung Transplant 11 1992 950 958
61. E. Shane, M. Rivas, and D.J. McMahon Bone loss and turnover after cardiac transplantation J Clin Endocrinol Metab 82 1997 1497 1506
62. E. Shane, V. Addesso, and P.B. Namerow Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation N Engl J Med 350 2004 767 776
63. N.O. Vidal, H. Brandstrom, K.B. Jonsson, and C. Ohlsson Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids J Endocrinol 159 1998 191 195
64. L.C. Hofbauer, F. Gori, and B.L. Riggs Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis Endocrinology 140 1999 4382 4389
65. S. Goral, C. Ynares, Y. Shyr, T.K. Yeoh, and H.K. Johnson Long-term renal function in heart transplant recipients receiving cyclosporine therapy J Heart Lung Transplant 16 1997 1106 1112
66. J. Stief, H.Y. Sohn, A. Alt, P. Uberfuhr, K. Theisen, and H.U. Stempfle Effect of immunosuppression-induced hypogonadism on bone metabolism after heart transplantation Dtsch Med Wochenschr 129 2004 1674 1678
67. P. Glendenning, G.N. Kent, and B.D. Adler High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry Clin Endocrinol (Oxf) 50 1999 347 355
68. G. Hofle, C.H. Saely, G. Tautermann, S. Aczel, H. Holzmuller, and H. Drexel Relationship between various measures of bone mineral density and vertebral fractures in cardiac transplant recipients Swiss Med Wkly 134 2004 215 220
69. K. Kerschan-Schindl, J. Strametz-Juranek, and G. Heinze Pathogenesis of bone loss in heart transplant candidates and recipients J Heart Lung Transplant 22 2003 843 8450
70. P. Sambrook Alfacalcidol and calcitriol in the prevention of bone loss after organ transplantation Calcif Tissue Int 65 1999 341 343
71. H.U. Stempfle, C. Werner, and U. Siebert The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol Transplantation 73 2002 547 552
72. K.G. Saag, R. Emkey, T.J. Schnitzer Glucocorticoid-Induced Osteoporosis Intervention Study Group Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis N Engl J Med 339 1998 292 299
73. K Henderson, J Eisman, and A Keogh Protective effect of short-term calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation J Bone Miner Res 16 2001 565 571
74. P Sambrook, NK Henderson, and A Keogh Effect of calcitriol on bone loss after cardiac or lung transplantation J Bone Miner Res 15 2000 1818 1824
75. T. Bianda, A. Linka, and G. Junga Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate Calcif Tissue Int 67 2000 116 121
76. H.M. Heshmati, B.L. Riggs, M.F. Burritt, C.A. McAlister, P.C. Wollan, and S. Khosla Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women J Clin Endocrinol Metab 83 1998 751 756
77. A.M. Bollen, M.D. Martin, B.G. Leroux, and D.R. Eyre Circadian variation in urinary excretion of bone collagen cross-links J Bone Miner Res 10 1995 1885 1890
78. N.K. Henderson, P.N. Sambrook, and P.J. Kelly Bone mineral loss and recovery after cardiac transplantation Lancet 346 1995 905